Euro unlikely to reverse despite European Central Bank easing plans — European Central Bank meeting preview
ECB's Lagarde will speak to the tweaks in policy and her thoughts on the economy going forward at 8:30 AM ET/1330 GMT when she holds her traditional press conference after the rate decision. European leaders are also about to finalize a 750-billion euro recovery fund this week. That money is slated to start flowing next year, although final approval of the program has been held up by a dispute with conservative nationalist governments in Hungary and Poland over conditions attached to the ...
Officials have indicated that little progress has been made since Saturday, when Johnson and von der Leyen tasked their negotiating teams with making a new push to reach an agreement. The UK and European Union have been trading for years without paying tariffs or conducting customs or border checks, all of which is set to change at the end of the Brexit transition period unless they are able to agree a new pact.
McConnell suggested the parties each abandon their demands and put the issues to the side until next year. "What I recommend is we set aside liability, we set aside state and local and we pass those things we can agree on knowing full well we'll be back at this after the first of the year", he said.
Exports in November rose 21.1% year-on-year, the fastest growth since February 2018, up on October's 11.4% increase and easily beating forecasts. In the first 11 months, they contributed a total of 13.47 trillion yuan to China's exports and imports, up 11.3 percent year on year, accounting for 46.4 percent of the total foreign trade value which was 4 percentage points higher than in the same period last year.
He said there will be no delays in the AstraZeneca vaccine rollout as the trials are more than enough for establishing efficacy and it will not affect emergency use authorization in Europe and certainly not in India. Clinical trials on the vaccine are also being carried out in the United Kingdom and Brazil, by Oxford University and AstraZeneca. Therefore, Covishield is safe and well-tolerated and can be used effectively for the prevention of COVID-19 in the targeted population.
Britain formally left the European Union in January, almost four years after a referendum on membership that split the nation down the middle and two months after Johnson won an election touting what he claimed was an "oven ready" Brexit deal.